AstraZeneca PLC
AZN · New York Stock Exchange · United KingdomAstraZeneca: ten-year therapy-area FCFF, full EV/equity bridge, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
PDF · 38 pages · PLDownload PDFOrdering a company valuation also supports the project’s development.
Help develop World Market Atlas — an independent project for individual investors. Your support helps us produce analyses and improve our tools.
One company, a full business review and a detailed cash-flow valuation. Research on developed-market companies with explicit assumptions, scenarios and sources.
AstraZeneca: ten-year therapy-area FCFF, full EV/equity bridge, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
Limitations and conventions: Screen-grade: secondary price; no paid consensus; sector beta, debt cost, diluted-share proxy and long-term paths are author assumptions. Not investment advice.
01 · Business and earnings qualitySegments, competition, historical financials, balance sheet, capital allocation and risks.
02 · Detailed modelRevenue and margin forecasts, taxes, capex, depreciation, working capital, leases and cash flows.
03 · Valuation and checksCost of capital, terminal value, equity-value bridge, scenarios, sensitivities, sources and limitations.
Reports retain their original data, model and publication date. Subsequent research does not update historical valuations.
Results: 22
AstraZeneca: ten-year therapy-area FCFF, full EV/equity bridge, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
PDF · 38 pages · PLDownload PDFJohnson & Johnson: ten-year Innovative Medicine and MedTech FCFF, full EV/equity bridge including claims, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
PDF · 38 pages · PLDownload PDFAlphabet: ten-year six-stream FCFF, separate Cloud and Services, full EV/equity bridge, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
PDF · 38 pages · PLDownload PDFCoca-Cola: ten-year five-segment FCFF, bottling refranchising, full EV/equity bridge, scenarios, sensitivity and reverse DCF. No rating or recommendation.
PDF · 35 pages · PLDownload PDFApple: ten-year category-based FCFF, separate Products and Services margins, full EV/equity bridge, scenarios, two sensitivity matrices and reverse DCF. No rating or recommendation.
PDF · 35 pages · PLDownload PDFAB Volvo: ten-year Industrial Operations FCFF, separate VFS residual-income model, full EV/equity bridge, three cases, WACC/g and reverse DCF. No rating or recommendation.
PDF · 35 pages · PLDownload PDFNestlé: ten-year FCFF by zone, explicit Russia and Waters deconsolidation, separate Waters/VMS proceeds bridge, three cases, WACC/g and reverse DCF. No rating or recommendation.
PDF · 36 pages · PLDownload PDFS&P Global after the Mobility spin: four-segment ten-year FCFF, full EV-to-equity bridge including redeemable NCI, three cases, WACC/g and reverse DCF. No rating or recommendation.
PDF · 34 pages · PLDownload PDFSAP: four revenue streams, a full ten-year FCFF, explicit cloud/support migration, SBC, M&A as reinvestment, scenarios, WACC/g and reverse DCF. No rating or recommendation.
PDF · 28 pages · PLDownload PDFTexas Instruments: three segments, a full ten-year FCFF, explicit CHIPS ITC and direct funding, fab capex/D&A, Silicon Labs overlay, scenarios, WACC/g and reverse DCF. No rating or recommendation.
PDF · 28 pages · PLDownload PDFKonecranes: three segments, a full ten-year FCFF model, explicit lease convention, guidance versus assumptions, scenarios, WACC/g and reverse DCF. No rating or recommendation.
PDF · 28 pages · PLDownload PDFDHL Group: five divisions, a full ten-year FCFF model, explicit lease convention, segment scenarios, WACC/g, reverse DCF, catalysts and falsification tests. No rating or recommendation.
PDF · 28 pages · PLDownload PDFLVMH: five business groups, a full ten-year FCFF model, explicit lease convention, scenarios, WACC/g, reverse DCF, China risks and falsification tests. No rating or recommendation.
PDF · 29 pages · PLDownload PDFAccenture: five industry groups, ten-year organic and acquisition growth forecast, explicit M&A cash cost, full FCFF, leases, benefits, WACC, scenarios, sensitivities and reverse DCF. No rating or recommendation.
PDF · 23 pages · PLDownload PDFPepsiCo: six segments, ten-year volume/price, cost and FCFF forecast, leases, benefits, working capital, scenarios, sensitivities and reverse DCF. Includes euro issuance and KFC risk. No rating or recommendation.
PDF · 24 pages · PLDownload PDFDetailed RELX model: Risk, STM, Legal, Exhibitions and Print, ten-year FCFF, costs, software, pre-publication, leases, JVs, scenarios, sensitivity and reverse DCF. No rating or recommendation.
PDF · 22 pages · PLDownload PDFDetailed Canadian National Railway model: seven commodity groups, RTM and yield/mix, ten-year FCFF, network costs, capex, NWC, leases, pensions, scenarios and reverse DCF. Conditional values with no rating or recommendation.
PDF · 20 pages · PLDownload PDFDetailed Novo Nordisk research: therapy and brand drivers, 340B earnings quality, a ten-year FCFF forecast, pipeline, patent cliff, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
PDF · 29 pages · PLDownload PDFDetailed Airbus research: delivery and segment drivers, a ten-year FCFF forecast, customer advances, programme risk, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
PDF · 28 pages · PLDownload PDFDetailed Nintendo research: an explicit Switch 2 platform cycle, seven revenue drivers, a ten-year FCFF forecast, balance sheet, associates, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
PDF · 26 pages · PLDownload PDFDetailed ASML research: three economic revenue drivers, a full ten-year FCFF forecast, balance-sheet and working-capital treatment, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
Technical correction · 15 October 2026PDF · 23 pages · PLDownload original PDFDetailed Microsoft research: eight revenue groups, the two new reporting segments, ten forecast years, AI reinvestment and lease conventions, scenarios and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
PDF · 26 pages · PLDownload PDFThis archive shows published reports. New reports appear after research, model checks and publication; the most recent report keeps its actual publication date.